Scientific Journals

	Original Artikel	Datum	Titel	Autoren Max. 6 Autoren
1	[GO]	2022―Okt―31	Exploring risks of investor claims brought forth after the TRIPS waiver for COVID-19	Shrikant Kulkarni, Varinder Kaur
2	[GO]	2022―Mai―31	Remdesivir: an overview of patenting trends, clinical evidence on COVID-19 treatment, pharmacology and chemistry	Sandro G Viveiros Rosa, Wilson C Santos
3	[GO]	2021―Jan―15	Repurposing drugs during the COVID-19 pandemic and beyond	Srividya Ravi, Sammita Jadhav, Anuradha Vaidya, Ravindra Ghooi